Geneos Wealth Management’s Centene CNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $84.8K | Hold |
1,321
| – | – | ﹤0.01% | 1273 |
|
|
2026
Q1 | $43.3K | Sell |
1,321
-175
| -12% | -$7.18K | ﹤0.01% | 1484 |
|
|
2025
Q4 | $61.6K | Hold |
1,496
| – | – | ﹤0.01% | 1316 |
|
|
2025
Q3 | $53.4K | Sell |
1,496
-401
| -21% | -$12.1K | ﹤0.01% | 1365 |
|
|
2025
Q2 | $103K | Buy |
1,897
+435
| +30% | +$25.5K | ﹤0.01% | 1235 |
|
|
2025
Q1 | $88.8K | Buy |
1,462
+641
| +78% | +$38.7K | ﹤0.01% | 1209 |
|
|
2024
Q4 | $49.7K | Buy |
821
+3
| +0.4% | +$187 | ﹤0.01% | 1326 |
|
|
2024
Q3 | $61.6K | Buy |
818
+208
| +34% | +$15.2K | ﹤0.01% | 1128 |
|
|
2024
Q2 | $40.4K | Sell |
610
-300
| -33% | -$21.8K | ﹤0.01% | 1141 |
|
|
2024
Q1 | $71.4K | Sell |
910
-302
| -25% | -$23.3K | ﹤0.01% | 951 |
|
|
2023
Q4 | $89.9K | Buy |
1,212
+52
| +4% | +$3.75K | ﹤0.01% | 870 |
|
|
2023
Q3 | $79.9K | Sell |
1,160
-5
| -0.4% | -$333 | ﹤0.01% | 932 |
|
|
2023
Q2 | $78.6K | Hold |
1,165
| – | – | ﹤0.01% | 944 |
|
|
2023
Q1 | $73.6K | Hold |
1,165
| – | – | ﹤0.01% | 941 |
|
|
2022
Q4 | $95.5K | Buy |
1,165
+602
| +107% | +$49.2K | 0.01% | 838 |
|
|
2022
Q3 | $43K | Sell |
563
-1,082
| -66% | -$96.7K | ﹤0.01% | 1073 |
|
|
2022
Q2 | $141K | Sell |
1,645
-69
| -4% | -$5.73K | 0.01% | 882 |
|
|
2022
Q1 | $144K | Buy |
1,714
+101
| +6% | +$8.28K | 0.01% | 945 |
|
|
2021
Q4 | $132K | Sell |
1,613
-1,623
| -50% | -$119K | 0.01% | 1065 |
|
|
2021
Q3 | $204K | Sell |
3,236
-3,861
| -54% | -$258K | 0.01% | 846 |
|
|
2021
Q2 | $524K | Buy |
7,097
+5,221
| +278% | +$358K | 0.02% | 552 |
|
|
2021
Q1 | $115K | Hold |
1,876
| – | – | ﹤0.01% | 1231 |
|
|
2020
Q4 | $121K | Buy |
1,876
+398
| +27% | +$25.3K | ﹤0.01% | 1050 |
|
|
2020
Q3 | $81K | Hold |
1,478
| – | – | ﹤0.01% | 1034 |
|
|
2020
Q2 | $88K | Hold |
1,478
| – | – | ﹤0.01% | 974 |
|
|
2020
Q1 | $81K | Buy |
1,478
+800
| +118% | +$48.5K | 0.01% | 913 |
|
|
2019
Q4 | $43K | Hold |
678
| – | – | ﹤0.01% | 1330 |
|
|
2019
Q3 | $29K | Hold |
678
| – | – | ﹤0.01% | 1437 |
|
|
2019
Q2 | $35K | Sell |
678
-114
| -14% | -$6.16K | ﹤0.01% | 1363 |
|
|
2019
Q1 | $42K | Buy |
792
+20
| +3% | +$1.21K | ﹤0.01% | 1226 |
|
|
2018
Q4 | $43K | Buy |
772
+54
| +8% | +$3.62K | ﹤0.01% | 1166 |
|
|
2018
Q3 | $51K | Buy |
718
+324
| +82% | +$22.5K | ﹤0.01% | 1166 |
|
|
2018
Q2 | $24K | Hold |
394
| – | – | ﹤0.01% | 1365 |
|
|
2018
Q1 | $21K | Hold |
394
| – | – | ﹤0.01% | 1366 |
|
|
2017
Q4 | $19K | Hold |
394
| – | – | ﹤0.01% | 1395 |
|
|
2017
Q3 | $19K | Sell |
394
-476
| -55% | -$20.5K | ﹤0.01% | 1327 |
|
|
2017
Q2 | $34K | Sell |
870
-38
| -4% | -$1.43K | ﹤0.01% | 1079 |
|
|
2017
Q1 | $32K | Sell |
908
-15,342
| -94% | -$513K | ﹤0.01% | 1056 |
|
|
2016
Q4 | $459K | Buy |
16,250
+15,402
| +1,816% | +$454K | 0.06% | 264 |
|
|
2016
Q3 | $28K | Buy |
848
+38
| +5% | +$1.32K | ﹤0.01% | 1010 |
|
|
2016
Q2 | $28K | Buy |
810
+228
| +39% | +$7.16K | ﹤0.01% | 1005 |
|
|
2016
Q1 | $17K | Buy |
+582
| New | +$17.4K | ﹤0.01% | 1135 |
|
Other funds holding CNC
Geneos Wealth Management's CNC Position: Q2 2026 in Review
Geneos Wealth Management held its Centene (CNC) position steady in Q2 2026 at 1,321 shares worth $84.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.
Geneos Wealth Management first reported a position in CNC in Q1 2016 and has held it in 42 quarters since. The position peaked at $524K in Q2 2021. 1,006 funds tracked by Wall St. Rank hold CNC as of Q2 2026.
- Geneos Wealth Management held 1,321 shares of Centene worth $84.8K as of Q2 2026.
- Geneos Wealth Management left its Centene share count unchanged in Q2 2026.
- Centene made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1273 holding.
- Geneos Wealth Management first reported a position in Centene in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's Centene position peaked at $524K in Q2 2021.
- 1,006 funds tracked by Wall St. Rank held Centene as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.